Tuesday 2 December, 2014 - 8:51
Yabonga, a non-governmental organisation (NGO) assisting HIV-positive children, says while antiretrovirals (ARV) are prolonging lives, the side-effects may slow down some patients’ academic development.
Yabonga counsels about 1 000 Cape Town children, some as young as five, who have HIV/AIDS, the organisation also runs various programmes including educational workshops and trauma counselling for HIV-positive kids.
Wednesday 11 December, 2013 - 10:58
New research suggests that some AIDS patients are developing drug intolerance and severe side effects and will now have to switch to new, more expensive antiretroviral regimens.
Researchers in Zimbabwe, Uganda, Nigeria and Malawi say some patients on the first-line antiretroviral drugs nevirapine and efavirenz (EFZ) are showing signs of being intolerant to the two drugs.
Tuesday 3 December, 2013 - 10:09
Starting HIV patients on antiretrovirals (ARV) earlier may save South Africa money in the short-term, but doctors caution that such a move may risk patients.
Friday 29 November, 2013 - 16:31
The Desmond Tutu HIV Foundation (DTHF) was established in the early 1990's, as part of one of the first public clinics in South Africa to offer antiretroviral therapy to those living with HIV. In January 2004 the Desmond Tutu HIV Foundation NPO was established at the Faculty of Health Sciences, University of Cape Town. Supported by Emeritus Archbishop Desmond and Mrs Leah Tutu, the Foundation's activities include HIV prevention, treatment, and training as well as tuberculosis screening and management among some of the most vulnerable communities of the Western Cape.
